Veracyte stands out in a pressured medical instruments industry as genAI adoption and rising sales forecasts fuel investor interest.

VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence. The team at ...

Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans, leading to multiple organ failure. Another example, ...

The Centers for Medicare & Medicaid Services (CMS) late last week announced the creation of the GENErating cost Reductions for US (GENEROUS) Medicaid Model, which will utilize most-favored nation ...

The GENEROUS Model aims to reduce Medicaid drug costs by aligning prices with international standards, launching in 2026. It builds on existing programs like the Medicaid Drug Rebate Program and the ...

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of administration to humans, leading to multiple organ failure. Another example, ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration announced that more than 140,000 bottles of a widely used generic cholesterol drug, atorvastatin calcium, are being voluntarily recalled ...

The FDA said that nearly 142,000 bottles were recalled because of failed dissolution specifications, meaning the medication did not dissolve as it should have, and may not work as effectively, Fox ...